This second edition provides an updated review on the current guidelines and practice standards for the clinical management of cardiovascular risk factors and prevention of cardiovascular diseases. Endorsed by the American Society for Preventive Cardiology, this practical textbook includes concise descriptions of major and newer risk factors, biomarkers, and best practices in the management and prevention of cardiovascular disease. The manual contains chapters on the epidemiology and risk factors for a variety of cardiovascular diseases including dyslipidemia, hypertension, diabetes, inflammation, and ischemic stroke. It examines behavioral factors, psychosocial stress, family history, nutrition, physical activity, smoking, alcohol use, and other sociocultural factors. In addition, the book discusses new imaging strategies in detection of cardiovascular disease, prevention of heart failure, atrial fibrillation, and peripheral arterial disease, and prevention for special populations. Throughout the manual, recommendations are based on guidelines endorsed by the American College of Cardiology, American Heart Association, and other major societies.
The second edition of the ASPC Manual of Preventive Cardiology is an essential resource for physicians, medical students, residents, fellows, nurses, and other healthcare professionals and researchers in cardiology, primary care, health promotion and disease prevention, exercise physiology, and pharmacotherapy.
|
Focus on Cardiovascular Health Promotion and Disease Prevention: Opportunities for Improvement |
|
|
1 | (16) |
|
|
|
|
|
|
|
National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk |
|
|
17 | (18) |
|
|
|
|
|
|
|
|
|
Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors |
|
|
35 | (26) |
|
|
|
|
|
Assessment and Management of Psychosocial Risk Factors Within Preventive Cardiology Practice |
|
|
61 | (12) |
|
|
|
Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction |
|
|
73 | (26) |
|
|
|
Physical Activity Strategies |
|
|
99 | (20) |
|
|
|
Obesity Management and Prevention of Cardiovascular Disease |
|
|
119 | (30) |
|
|
|
|
|
|
|
149 | (14) |
|
|
|
Alcohol and Cardiovascular Diseases |
|
|
163 | (16) |
|
|
|
|
|
The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: A Personalized Approach to Risk Reduction |
|
|
179 | (22) |
|
|
|
|
|
|
|
Blood Pressure and Hypertension Management |
|
|
201 | (26) |
|
|
|
|
|
Cardiodiabetology: Reducing Risks to Optimize Cardiovascular Disease Outcomes |
|
|
227 | (22) |
|
|
|
|
|
|
|
249 | (40) |
|
|
|
|
|
Inflammation and Atherosclerotic Cardiovascular Disease |
|
|
289 | (46) |
|
|
|
The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests |
|
|
335 | (30) |
|
|
|
Exercise Electrocardiographic Stress Testing |
|
|
365 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ultrasound and MRI Assessment of Cardiovascular Risk |
|
|
391 | (26) |
|
|
|
|
|
|
|
Role of CT Coronary Calcium Scanning and Angiography in Evaluation of Cardiovascular Risk |
|
|
417 | (24) |
|
|
|
|
|
|
|
Cardiovascular Disease Prevention in Women |
|
|
441 | (22) |
|
|
|
|
|
Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease |
|
|
463 | (26) |
|
|
|
|
|
|
|
Prevention of Heart Failure |
|
|
489 | (24) |
|
|
|
|
|
Prevention of Peripheral Arterial Disease |
|
|
513 | (28) |
|
|
|
|
|
|
|
Prevention of Atrial Fibrillation |
|
|
541 | (40) |
|
|
|
|
|
Prevention of Ischemic Stroke |
|
|
581 | (30) |
|
|
|
|
|
Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease |
|
|
611 | (42) |
|
|
|
|
|
Primary Prevention of Cardiovascular Disease Guidelines |
|
|
653 | (20) |
|
|
|
|
|
|
|
Secondary Prevention and Cardiac Rehabilitation |
|
|
673 | (32) |
|
|
|
|
|
|
|
|
|
Integrative Approaches for Cardiovascular Disease Prevention |
|
|
705 | (28) |
|
|
|
|
|
Preventive Cardiology as Specialized Medical Art |
|
|
733 | (12) |
|
|
|
|
| Index |
|
745 | |
Nathan D. Wong, PhD, FACC, FAHA, FASPC, FNLA
Professor and Director, Heart Disease Prevention Program
Division of Cardiology, University of California, Irvine
Adjunct Professor of Epidemiology (UCLA and UC Irvine) and Population Sciences (UC Irvine)
Past President, American Society for Preventive Cardiology
C240 Medical Sciences
Irvine, CA 92697-4079, USA
T: 949-824-5561
Email: ndwong@uci.edu
Ezra A. Amsterdam, MD, FACC, FAHA
Distinguished Professor of Medicine
Associate Chief, Division of Cardiovascular Medicine
Past President, American Society for Preventive Cardiology
Department of Internal Medicine
University of California (Davis) Medical Center
4086 Y Street
Sacramento, CA 95817, USA
T: 916-734-5191
Email: eaamsterdam@ucdmc.edu
Peter P. Toth, MD, PhD, FAAFP, FCCP, FNLA, FASPC, FESC, FACC
Professor of Clinical Family and Community Medicine
University of Illinois School of Medicine
Adjunct Associate Professor of Medicine
Ciccarone Center for Cardiovascular Disease Prevention, Johns Hopkins University
President, American Society for Preventive Cardiology
101 East Miller Road
Sterling, IL 61081, USA
Email: Peter.Toth@cghmc.com
Biežāk uzdotie jautājumi par e-grāmatām